Stock CVKD CADRENAL THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Comparison Chart Cadrenal Therapeutics, Inc.

Equities

CVKD

US1276361086

Delayed Nasdaq
Other stock markets
 12:08:36 2024-06-27 pm EDT 		5-day change 1st Jan Change
0.4608 USD -2.36% Intraday chart for Cadrenal Therapeutics, Inc. +0.39% -37.72%
May. 09 Cadrenal Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Apr. 09 Cadrenal Therapeutics Receives FDA Orphan Drug Designation for Tecarfarin for Prevention of Thromboembolism and Thrombosis in Patients with LVADs, RVADs, Biventricular Assist Devices, and Total Artificial Hearts CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
CADRENAL THERAPEUTICS, INC.
Other Pharmaceuticals
-2.36%+0.39%-37.72%-71.38% - 7.56M
Neutral
Bearish
Bearish

Technical Rankings Surperformance

  1. Stock Market
  2. Equities
  3. CVKD Stock
  4. Charts Cadrenal Therapeutics, Inc.
  5. Comparison Chart